CSIMarket
 
Evogene Ltd   (NASDAQ: EVGN)
 

Evogene Ltd's Customers Performance

EVGN



 
EVGN's Source of Revenues During the corresponding time, Evogene Ltd saw a revenue deteriorated by -54.73 % year on year, While revenue at the Evogene Ltd 's corporate clients

List of EVGN Customers




for the same period Evogene Ltd revnue deteriorated by -54.73 % year on year,

List of EVGN Customers

Evogene Ltd's Business Units
Revenue Recognized At A Point In Time    65.38 % of total Revenue
Revenue Recognized Over Time    34.62 % of total Revenue
Agriculture    35.66 % of total Revenue
Industrial application    56.27 % of total Revenue
Unallocated    8.07 % of total Revenue
Customer A subsidiary shareholder    9.08 % of total Revenue
Customer B Member    22.84 % of total Revenue
Customer C Member    52.74 % of total Revenue
United States    0 % of total Revenue
Israel    0 % of total Revenue
Europe    0 % of total Revenue
Africa    0 % of total Revenue






Evogene Ltd's Comment on Sales, Marketing and Customers



The company provides services to collaborators who develop and commercialize products based on the company's licensed discoveries, including castor bean seeds. Its revenues are derived from fees for research and development services, milestone payments, and royalties from collaborators. The company encounters challenges in collecting royalties and potential disputes regarding intellectual property rights with collaborators. Additionally, competition for skilled scientific, technical, and other personnel in Israel's high-tech and biotech industries affects its operations.





Evogene Ltd’s Comment on Sales, Marketing and Customers


The company provides services to collaborators who develop and commercialize products based on the company's licensed discoveries, including castor bean seeds. Its revenues are derived from fees for research and development services, milestone payments, and royalties from collaborators. The company encounters challenges in collecting royalties and potential disputes regarding intellectual property rights with collaborators. Additionally, competition for skilled scientific, technical, and other personnel in Israel's high-tech and biotech industries affects its operations.








EVGN's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Evogene Ltd 3.56 3.85 -7.83 31
SUBTOTAL 0.00 0.00 0.00 -

Sources: Evogene Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Evogene Ltd’s corporate clients.
For your research, we’ve provided 9 tables on Evogene Ltd corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.